Skip Navigation LinksHome > August 2014 - Volume 19 - Issue 4 > Acceptable mismatching at the class II epitope level: the C...
Current Opinion in Organ Transplantation:
doi: 10.1097/MOT.0000000000000104
HISTOCOMPATIBILITY: Edited by RenE J. Duquesnoy

Acceptable mismatching at the class II epitope level: the Canadian experience

Wiebe, Chrisa; Nickerson, Petera,b

Collapse Box


Purpose of review: To summarize the evidence concerning human leukocyte antigen (HLA) epitope mismatch analysis as a means to predict donor-specific antibody (DSA) development and allograft survival.

Recent findings: HLA epitope mismatch analysis outperforms traditional whole molecule antigen mismatch for predicting the risk of de-novo DSA development. By analyzing the number of epitope mismatches for a given donor-recipient pair, thresholds have been identified to stratify patients into those at high or low risk of de-novo DSA development. Epitope specificity assignment in patients who develop de-novo DSA compared with controls who do not provides an opportunity to study the relative immunogenicity of mismatched HLA epitopes.

Summary: Recognizing that de-novo DSA is a major cause of graft loss, HLA epitope mismatch analysis is a strategy to minimize de-novo DSA development and improve long-term graft survival.

© 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.